Aditi Shendre1, Gaurav M Parmar2, Chrisly Dillon3, Timothy Mark Beasley4, Nita A Limdi3. 1. Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University-Purdue University Indianapolis, Indianapolis, Indiana. 2. Division of Vascular Surgery and Endovascular Therapy, University of Alabama at Birmingham, Birmingham, Alabama. 3. Department of Neurology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama. 4. Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama.
Abstract
OBJECTIVE: We assessed the influence of age on warfarin dose, percentage time in target range (PTTR), and risk of major hemorrhage. DESIGN: Warfarin users recruited into a large prospective inception cohort study were categorized into three age groups: young (younger than 50 yrs), middle aged (50-70 yrs), and elderly (older than 70 yrs). The influence of age on warfarin dose and PTTR was assessed using regression analysis; risk of major hemorrhage was assessed using proportional hazards analysis. Models were adjusted for demographic, clinical, and genetic factors. SETTING: Two outpatient anticoagulation clinics. PARTICIPANTS: A total of 1498 anticoagulated patients. OUTCOMES: Warfarin dose (mg/day), PTTR, major hemorrhage. RESULTS: Of the 1498 patients, 22.8% were young, 44.1% were middle aged, and 33.1% were elderly. After accounting for clinical and genetic factors, compared with young warfarin users, warfarin dose requirements were 10.6% lower among the middle aged and an additional 10.6% lower for the elderly. Compared with young patients, middle-aged and elderly patients spent more time in target international normalized ratio (INR) range (p<0.0001), despite having fewer INR assessments (p<0.0001). Compared with young warfarin users, absolute risk of hemorrhage was marginally higher among the middle aged (p=0.08) and significantly higher among the elderly (p=0.016). Compared with young warfarin users, after adjustment, the relative risk of hemorrhage increased by 31% for each age category (p=0.026). CONCLUSIONS: In a real-world setting, despite achieving better anticoagulation control, elderly patients had a higher risk of major hemorrhagic events. As the population ages and the candidacy for oral anticoagulation increases, strategies that mitigate the elevated risk of hemorrhage need to be identified.
OBJECTIVE: We assessed the influence of age on warfarin dose, percentage time in target range (PTTR), and risk of major hemorrhage. DESIGN:Warfarin users recruited into a large prospective inception cohort study were categorized into three age groups: young (younger than 50 yrs), middle aged (50-70 yrs), and elderly (older than 70 yrs). The influence of age on warfarin dose and PTTR was assessed using regression analysis; risk of major hemorrhage was assessed using proportional hazards analysis. Models were adjusted for demographic, clinical, and genetic factors. SETTING: Two outpatient anticoagulation clinics. PARTICIPANTS: A total of 1498 anticoagulated patients. OUTCOMES: Warfarin dose (mg/day), PTTR, major hemorrhage. RESULTS: Of the 1498 patients, 22.8% were young, 44.1% were middle aged, and 33.1% were elderly. After accounting for clinical and genetic factors, compared with young warfarin users, warfarin dose requirements were 10.6% lower among the middle aged and an additional 10.6% lower for the elderly. Compared with young patients, middle-aged and elderly patients spent more time in target international normalized ratio (INR) range (p<0.0001), despite having fewer INR assessments (p<0.0001). Compared with young warfarin users, absolute risk of hemorrhage was marginally higher among the middle aged (p=0.08) and significantly higher among the elderly (p=0.016). Compared with young warfarin users, after adjustment, the relative risk of hemorrhage increased by 31% for each age category (p=0.026). CONCLUSIONS: In a real-world setting, despite achieving better anticoagulation control, elderly patients had a higher risk of major hemorrhagic events. As the population ages and the candidacy for oral anticoagulation increases, strategies that mitigate the elevated risk of hemorrhage need to be identified.
Authors: Jonathan C Hsu; Thomas M Maddox; Kevin F Kennedy; David F Katz; Lucas N Marzec; Steven A Lubitz; Anil K Gehi; Mintu P Turakhia; Gregory M Marcus Journal: JAMA Cardiol Date: 2016-04-01 Impact factor: 14.676
Authors: Nadine Shehab; Maribeth C Lovegrove; Andrew I Geller; Kathleen O Rose; Nina J Weidle; Daniel S Budnitz Journal: JAMA Date: 2016-11-22 Impact factor: 56.272
Authors: Brian F Gage; Yan Yan; Paul E Milligan; Amy D Waterman; Robert Culverhouse; Michael W Rich; Martha J Radford Journal: Am Heart J Date: 2006-03 Impact factor: 4.749
Authors: Tu Ngoc Nguyen; Marie-Christine Morel-Kopp; Dominic Pepperell; Robert Graham Cumming; Sarah Nicole Hilmer; Christopher Morice Ward Journal: Aging Clin Exp Res Date: 2017-03-02 Impact factor: 3.636
Authors: Stuart J Connolly; Janice Pogue; John Eikelboom; Gregory Flaker; Patrick Commerford; Maria Grazia Franzosi; Jeffrey S Healey; Salim Yusuf Journal: Circulation Date: 2008-10-27 Impact factor: 29.690
Authors: Lindsay M Henderson; Renee F Robinson; Lily Ray; Burhan A Khan; Tianran Li; Denise A Dillard; Brian D Schilling; Mike Mosley; Patricia L Janssen; Alison E Fohner; Allan E Rettie; Kenneth E Thummel; Timothy A Thornton; David L Veenstra Journal: Clin Transl Sci Date: 2019-03-01 Impact factor: 4.689
Authors: Natalia A Shnayder; Marina M Petrova; Pavel A Shesternya; Alina V Savinova; Elena N Bochanova; Olga V Zimnitskaya; Elena A Pozhilenkova; Regina F Nasyrova Journal: Biomedicines Date: 2021-04-22
Authors: Zeina N Al-Mahayri; Lubna Q Khasawneh; Mais N Alqasrawi; Sahar M Altoum; Gohar Jamil; Sally Badawi; Dana Hamza; Lizy George; Anwar AlZaabi; Husam Ouda; Fatma Al-Maskari; Juma AlKaabi; George P Patrinos; Bassam R Ali Journal: Hum Genomics Date: 2022-09-25 Impact factor: 6.481
Authors: Xi Zhang; Guang-Yu Chen; Zhao-Xia Wang; Xue-Hai Li; Rong Luo; Yi-Gang Li; Fan Yang; Xin Zhou; Feng Jiang; Yao-Sheng Wang Journal: Ann Transl Med Date: 2020-08